These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 9724385)
1. Adsorption of technetium-99m tetrofosmin and technetium-99m furifosmin on plastic syringes. Bartosch R; Granegger S; Sinzinger H Eur J Nucl Med; 1998 Sep; 25(9):1333-5. PubMed ID: 9724385 [TBL] [Abstract][Full Text] [Related]
2. Adsorption of some technetium-99m radiopharmaceuticals onto disposable plastic syringes. Jansson BA; Göransson MB; Agren BN J Nucl Med Technol; 1998 Sep; 26(3):196-9. PubMed ID: 9755440 [TBL] [Abstract][Full Text] [Related]
3. Adsorption of (99m)Tc-radiopharmaceuticals onto injection vials and syringes. Mushtaq A; Ur Rehman T; Safdar Mansur M; Jehangir M J Nucl Med Technol; 2008 Jun; 36(2):91-4. PubMed ID: 18483140 [TBL] [Abstract][Full Text] [Related]
4. Systematic Assessment of the Adsorption of Kvaternik H; Gatterer J; Plhak E; Schwarzgruber JF; Aigner RM J Nucl Med Technol; 2020 Jun; 48(2):168-173. PubMed ID: 31811065 [TBL] [Abstract][Full Text] [Related]
5. Adsorption of radiopharmaceuticals to syringes leads to lower administered activity than intended. Gunasekera RD; Notghi A; Mostafa AB; Harding LK Nucl Med Commun; 2001 May; 22(5):493-7. PubMed ID: 11388569 [TBL] [Abstract][Full Text] [Related]
6. In vitro adsorption of 99Tc(m)-MIBI, 99Tc(m)-tetrofosmin, 99Tc(m)-furifosmin and 99Tc(m)O4- onto tubes. Rodrigues M; Chehne F; Sinzinger H Nucl Med Commun; 2001 Jan; 22(1):105-10. PubMed ID: 11233544 [TBL] [Abstract][Full Text] [Related]
7. 201Tl, 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin: relative retention and clearance kinetics in retrogradely perfused guinea pig hearts. Schaefer WM; Moka D; Brockmann HA; Schomaecker K; Schicha H Nucl Med Biol; 2002 Feb; 29(2):243-54. PubMed ID: 11823130 [TBL] [Abstract][Full Text] [Related]
8. Comparative 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-furifosmin uptake in human soft tissue sarcoma cell lines. Rodriques M; Chehne F; Kalinowska W; Zielinski C; Sinzinger H Eur J Nucl Med; 2000 Dec; 27(12):1839-43. PubMed ID: 11189948 [TBL] [Abstract][Full Text] [Related]
9. Impact of disposable syringes type choice on myocardial perfusion imaging procedures with [ Ladriere T; Desmonts C; Zimmermann PA; Peyronnet D; Agostini D; Vigne J J Nucl Cardiol; 2023 Aug; 30(4):1399-1405. PubMed ID: 36352084 [TBL] [Abstract][Full Text] [Related]
10. [Impact of Residual Radioactivity Rate of Nakamura Y; Kangai Y; Sato S; Shibata S; Abe T; Mimura H; Inubushi M Nihon Hoshasen Gijutsu Gakkai Zasshi; 2023 Aug; 79(8):802-809. PubMed ID: 37357400 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of the stability of (99m)Tc-ECD and stabilized (99m)Tc-HMPAO stored in syringes. Koslowsky IL; Brake SE; Bitner SJ J Nucl Med Technol; 2001 Dec; 29(4):197-200. PubMed ID: 11756532 [TBL] [Abstract][Full Text] [Related]
12. Preparation of 99mTc-MAG3: radiochemical purity is affected by the residence time of sodium chloride injection in a three-part syringe. Waight CC; Beattie LA; O'Brien LM; Millar AM Nucl Med Commun; 2006 Feb; 27(2):197-200. PubMed ID: 16404235 [TBL] [Abstract][Full Text] [Related]
13. Adsorption of radiopharmaceuticals to syringes: setting up a reliable protocol for its assessment. Stopar TG; Socan A; Peitl PK Nucl Med Commun; 2007 Dec; 28(12):951-5. PubMed ID: 18090223 [TBL] [Abstract][Full Text] [Related]
14. Comparative myocardial uptake of technetium-99 m sestamibi and technetium-99m tetrofosmin one hour after stress injection. Gremillet E; Champailler A Eur J Nucl Med; 1998 Nov; 25(11):1502-10. PubMed ID: 9799346 [TBL] [Abstract][Full Text] [Related]
15. First experiences with technetium-99m furifosmin as tumour-seeking agent in breast cancer and recurrent ovarian cancer. Aigner RM; Fueger GF Eur J Nucl Med; 1997 Sep; 24(9):1167-70. PubMed ID: 9283112 [TBL] [Abstract][Full Text] [Related]
16. Quantitative comparison of planar and SPECT normal data files of thallium-201, technetium-99m-sestamibi, technetium-99m-tetrofosmin and technetium-99m-furifosmin. Naruse H; Daher E; Sinusas A; Jain D; Natale D; Mattera J; Makuch R; Wackers FJ J Nucl Med; 1996 Nov; 37(11):1783-8. PubMed ID: 8917175 [TBL] [Abstract][Full Text] [Related]
17. Technetium-99m-furifosmin as an agent for functional imaging of multidrug resistance in tumors. Ballinger JR; Muzzammil T; Moore MJ J Nucl Med; 1997 Dec; 38(12):1915-9. PubMed ID: 9430469 [TBL] [Abstract][Full Text] [Related]
18. Myocardial technetium-99m-tetrofosmin and technetium-99m-sestamibi kinetics in normal subjects and patients with coronary artery disease. Münch G; Neverve J; Matsunari I; Schröter G; Schwaiger M J Nucl Med; 1997 Mar; 38(3):428-32. PubMed ID: 9074532 [TBL] [Abstract][Full Text] [Related]
19. Comparison of uptake of 99mTc-MIBI, 99mTc-tetrofosmin and 99mTc-Q12 into human breast cancer cell lines. de Jong M; Bernard BF; Breeman WA; Ensing G; Benjamins H; Bakker WH; Visser TJ; Krenning EP Eur J Nucl Med; 1996 Oct; 23(10):1361-6. PubMed ID: 8781141 [TBL] [Abstract][Full Text] [Related]
20. Adsorption of 99mTc-sestamibi onto plastic syringes: evaluation of factors affecting the degree of adsorption and their impact on clinical studies. Swanson TN; Troung DT; Paulsen A; Hruska CB; O'Connor MK J Nucl Med Technol; 2013 Dec; 41(4):247-52. PubMed ID: 24212450 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]